TNF-α promoter variant (G-308A) is associated with susceptibility to P. falciparum infection and severe malaria: a meta-analysis and trial sequential analysis

References

• Organization WH: World malaria report 2021; 2021.
   Google Scholar
• Miller, L. H.; Baruch, D. I.; Marsh, K.; Doumbo, O. K. The Pathogenic Basis of Malaria. Nature 2002, 415, 673–679. DOI: 10.1038/415673a.
   PubMed Web of Science ®Google Scholar
• Leão, L.; Puty, B.; Dolabela, M. F.; Povoa, M. M.; Né, Y. G. D. S.; Eiró, L. G.; Fagundes, N. C. F.; Maia, L. C.; Lima, R. R. Association of Cerebral Malaria and TNF-α Levels: A Systematic Review. BMC Infect. Dis. 2020, 20, 442. DOI: 10.1186/s12879-020-05107-2.
   PubMed Web of Science ®Google Scholar
• Sato, S. Plasmodium – A Brief Introduction to the Parasites Causing Human Malaria and Their Basic Biology. J. Physiol. Anthropol. 2021, 40, 1. DOI: 10.1186/s40101-020-00251-9.
   PubMed Web of Science ®Google Scholar
• Naing, C.; Whittaker, M. A.; Nyunt Wai, V.; Mak, J. W. Is Plasmodium vivax Malaria a Severe Malaria?: A Systematic Review and Meta-Analysis. PLoS Negl. Trop. Dis. 2014, 8, e3071. DOI: 10.1371/journal.pntd.0003071.
   PubMed Web of Science ®Google Scholar
• Furini, A. A.; Cassiano, G. C.; Petrolini Capobianco, M.; Dos Santos, S. E.; Dantas Machado, R. L. Frequency of TNFA, INFG, and IL10 Gene Polymorphisms and Their Association with Malaria vivax and Genomic Ancestry. Mediat. Inflamm. 2016, 2016, 5168363. DOI: 10.1155/2016/5168363.
   PubMed Web of Science ®Google Scholar
• Depinay, N.; Franetich, J. F.; Grüner, A. C.; Mauduit, M.; Chavatte, J.-M.; Luty, A. J. F.; van Gemert, G.-J.; Sauerwein, R. W.; Siksik, J.-M.; Hannoun, L.; et al. Inhibitory Effect of TNF-α on Malaria Pre-Erythrocytic Stage Development: Influence of Host Hepatocyte/Parasite Combinations. PLoS One 2011, 6, e17464. DOI: 10.1371/journal.pone.0017464.
   PubMed Web of Science ®Google Scholar
• Clark, I. A.; Budd, A. C.; Alleva, L. M.; Cowden, W. B. Human Malarial Disease: A Consequence of Inflammatory Cytokine Release. Malar J. 2006, 5, 85. DOI: 10.1186/1475-2875-5-85.
   PubMed Web of Science ®Google Scholar
• Vengesai, A.; Marume, A.; Midzi, H.; Kasambala, M.; Naicker, T.; Mduluza, T. Association of TNF (rs1800629) Promoter Polymorphism and Schistosomiasis with Sub-Microscopic Asymptomatic Plasmodium falciparum Infections in a Schistosomiasis-Endemic Area in Zimbabwe. Trop. Med. Int. Health 2021, 26, 366–373. DOI: 10.1111/tmi.13527.
   PubMed Web of Science ®Google Scholar
• Wells, G. A.; Shea, B.; O’Connell, D.; Peterson, J.; Welch, V.; Losos, M.; et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Oxford; 2000. https://ctu.dk/wp-content/uploads/2021/03/2017-10-10-TSA-Manual-ENG_ER.pdf
   Google Scholar
• Thorlund, K.; Engstrøm, J.; Wetterslev, J.; Brok, J.; Imberger, G.; Gluud, C. Trial Sequential Analysis (TSA). BMC Infect. Dis; 2011.
   Google Scholar
• Singh, K. P.; Shakeel, S.; Naskar, N.; Bharti, A.; Kaul, A.; Anwar, S.; Kumari, S.; Kumar, A.; Singh, J. K.; Kumari, N.; et al. Role of IL-1β, IL-6 and TNF-α Cytokines and TNF-α Promoter Variability in Plasmodium vivax Infection During Pregnancy in Endemic Population of Jharkhand, India. Mol. Immunol. 2018, 97, 82–93. DOI: 10.1016/j.molimm.2018.03.019.
   PubMed Web of Science ®Google Scholar
• Mahto, H.; Tripathy, R.; Meher, B. R.; Prusty, B. K.; Sharma, M.; Deogharia, D.; Saha, A. K.; Panda, A. K.; Das, B. K. TNF-α Promoter Polymorphisms (G-238A and G-308A) Are Associated with Susceptibility to Systemic Lupus Erythematosus (SLE) and P. falciparum Malaria: A Study in Malaria Endemic Area. Sci. Rep. 2019, 9, 11752. DOI: 10.1038/s41598-019-48182-5.
   PubMed Web of Science ®Google Scholar
• Mendonça, V. R. R.; Souza, L. C. L.; Garcia, G. C.; Magalhães, B. M. L.; Lacerda, M. V. G.; Andrade, B. B.; Gonçalves, M. S.; Barral-Netto, M. DDX39B (BAT1), TNF and IL6 Gene Polymorphisms and Association with Clinical Outcomes of Patients with Plasmodium vivax Malaria. Malar J. 2014, 13, 278. DOI: 10.1186/1475-2875-13-278.
   PubMed Web of Science ®Google Scholar
• Mergani, A.; Khamis, A. H.; Haboor, A. B.; Gumma, H. E.; Awadelseed Bet Al, M. Lack of Association between-308 Tumor Necrosis Factor Polymorphism and Susceptibility to Cerebral Malaria among Central Sudanese Children. Int. J. Genet. Mol. Biol. 2010, 2, 67.
   Google Scholar
• Ojurongbe, O.; Funwei, R. I.; Snyder, T. J.; Farid, I.; Aziz, N.; Li, Y.; Falade, C. O.; Thomas, B. N. Genetic Variants of Tumor Necrosis Factor-α -308G/A (rs1800629) but Not Toll-Interacting Proteins or Vitamin D Receptor Genes Enhances Susceptibility and Severity of Malaria Infection. Immunogenetics 2018, 70, 135–140. DOI: 10.1007/s00251-017-1032-4.
   PubMed Web of Science ®Google Scholar
• Olaniyan, S. A.; Amodu, O. K.; Bakare, A. A.; Troye-Blomberg, M.; Omotade, O. O.; Rockett, K. A, MalariaGEN Consortium Tumour Necrosis Factor Alpha Promoter Polymorphism, TNF-238 is Associated with Severe Clinical Outcome of falciparum Malaria in Ibadan Southwest Nigeria. Acta Trop. 2016, 161, 62–67. DOI: 1016/j.actatropica.2016.05.006. DOI: 10.1016/j.actatropica.2016.05.006.
   PubMed Web of Science ®Google Scholar
• Sohail, M.; Kaul, A.; Bali, P.; Raziuddin, M.; Singh, M. P.; Singh, O. P.; Dash, A. P.; Adak, T. Alleles -308A and -1031C in the TNF-Alpha Gene Promoter Do Not Increase the Risk but Associated with Circulating Levels of TNF-Alpha and Clinical Features of vivax Malaria in Indian Patients. Mol. Immunol. 2008, 45, 1682–1692. DOI: 10.1016/j.molimm.2007.10.002.
   PubMed Web of Science ®Google Scholar
• Sortica, V. A.; Cunha, M. G.; Ohnishi, M. D. O.; Souza, J. M.; Ribeiro-Dos-Santos, A. K. C.; Santos, N. P. C.; Callegari-Jacques, S. M.; Santos, S. E. B.; Hutz, M. H. IL1B, IL4R, IL12RB1 and TNF Gene Polymorphisms are Associated with Plasmodium vivax Malaria in Brazil. Malar J. 2012, 11, 409. DOI: 10.1186/1475-2875-11-409.
   PubMed Web of Science ®Google Scholar
• Mohanty, S.; Singh, U. S.; Mohanty, S.; Mohanty, A. K.; Pande, V.; Das, A. Evolutionary Interplay of Single Nucleotide Polymorphisms at the Promoter Region of TNF-α Gene in Different Clinical Outcomes of Malaria in India. Infect. Genet. Evol. 2019, 69, 107–116. DOI: 10.1016/j.meegid.2019.01.025.
   PubMed Web of Science ®Google Scholar
• Oyedeji, S. I.; Awobode, H. O.; Bassi, P. U.; Jürgen, F. K. 308G > A (rs1800629) and −244G > A(rs673) Polymorphisms at the Promoter Region of the TNF-α Gene in Severe Malaria Patients in North-Central Nigeria. Nig. J. Para 2017, 38, 205. DOI: 10.4314/njpar.v38i2.13.
   Google Scholar
• Shaffer, N.; Grau, G. E.; Hedberg, K.; Davachi, F.; Lyamba, B.; Hightower, A. W.; Breman, J. G.; Phuc, N. D. Tumor Necrosis Factor and Severe Malaria. J. Infect. Dis. 1991, 163, 96–101. DOI: 10.1093/infdis/163.1.96.
   PubMed Web of Science ®Google Scholar
• Erken, E.; Akbaba, M.; Günesaçar, R.; Demirhindi, H.; Hergüvenç, T. Serum Tumor Necrosis Factor Alpha Levels in Plasmodium vivax Malaria. J. Islamic Acad. Sci. 1993, 6, 259.
   Google Scholar
• Cruz, L. N.; Wu, Y.; Ulrich, H.; Craig, A. G.; Garcia, C. R. S. Tumor Necrosis Factor Reduces Plasmodium falciparum Growth and Activates Calcium Signaling in Human Malaria Parasites. Biochim. Biophys. Acta 2016, 1860, 1489–1497. DOI: 10.1016/j.bbagen.2016.04.003.
   PubMed Web of Science ®Google Scholar
• Orago, A.; Facer, C. Cytokine‐Induced Inhibition of Plasmodium falciparum Erythrocytic Growth In Vitro. Clin. Exp. Immunol. 1993, 91, 287–294. DOI: 10.1111/j.1365-2249.1993.tb05897.x.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski, D. Tumour Necrosis Factor, Fever and Fatality in falciparum Malaria. Immunol. Lett. 1990, 25, 213–216. DOI: 10.1016/0165-2478(90)90117-9.
   PubMed Web of Science ®Google Scholar
• Singh, S.; Singh, N.; Handa, R. Tumor Necrosis Factor-Alpha in Patients with. Ind. J. Malariol. 2000, 37, 27–33.
   PubMedGoogle Scholar
• Springer, T. A. Adhesion Receptors of the Immune System. Nature 1990, 346, 425–434. DOI: 10.1038/346425a0.
   PubMed Web of Science ®Google Scholar